Nuveen
VYGR icon

Nuveen’s Voyager Therapeutics VYGR Stock Holding History

Nuveen’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Hold
117,100
– – ﹤0.01% 3357
2026
Q1 		$452K Buy
117,100
+23,939
+26% +$94.2K ﹤0.01% 2881
2025
Q4 		$366K Hold
93,161
– – ﹤0.01% 2987
2025
Q3 		$435K Hold
93,161
– – ﹤0.01% 2944
2025
Q2 		$290K Sell
93,161
-15,628
-14% -$50.4K ﹤0.01% 3071
2025
Q1 		$368K Hold
108,789
– – ﹤0.01% 2989
2024
Q4 		$617K Hold
108,789
– – ﹤0.01% 2909
2024
Q3 		$636K Hold
108,789
– – ﹤0.01% 2933
2024
Q2 		$861K Buy
108,789
+19,424
+22% +$163K ﹤0.01% 2789
2024
Q1 		$832K Hold
89,365
– – ﹤0.01% 2775
2023
Q4 		$754K Buy
89,365
+940
+1% +$6.82K ﹤0.01% 2850
2023
Q3 		$685K Hold
88,425
– – ﹤0.01% 2731
2023
Q2 		$1.01M Buy
+88,425
New +$915K ﹤0.01% 2657
2021
Q2 		– Sell
-89,401
Closed -$421K – 3541
2021
Q1 		$421K Sell
89,401
-3,681
-4% -$25.1K ﹤0.01% 3126
2020
Q4 		$665K Sell
93,082
-181,223
-66% -$1.74M ﹤0.01% 2949
2020
Q3 		$2.93M Sell
274,305
-133,134
-33% -$1.56M ﹤0.01% 2197
2020
Q2 		$5.14M Sell
407,439
-7,310
-2% -$85K ﹤0.01% 1883
2020
Q1 		$3.79M Sell
414,749
-224
-0.1% -$2.57K ﹤0.01% 1869
2019
Q4 		$5.79M Sell
414,973
-107,086
-21% -$1.56M ﹤0.01% 1907
2019
Q3 		$8.98M Buy
522,059
+264,574
+103% +$5.55M ﹤0.01% 1643
2019
Q2 		$7.01M Buy
+257,485
New +$5.89M ﹤0.01% 1810

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen's VYGR Position: Q2 2026 in Review

Nuveen held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 117,100 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #3357.

Nuveen first reported a position in VYGR in Q2 2019 and has held it in 21 quarters since. The position peaked at $8.98M in Q3 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Nuveen held 117,100 shares of Voyager Therapeutics worth $410K as of Q2 2026.
  • Nuveen left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3357 holding.
  • Nuveen first reported a position in Voyager Therapeutics in Q2 2019 and has held it in 21 quarters since.
  • Nuveen's Voyager Therapeutics position peaked at $8.98M in Q3 2019.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.